Your browser doesn't support javascript.
loading
Is Somatostatin Receptor and Dopamine Receptor profiling useful in the management of silent somatotroph tumors?
Martínez-López, S; García-Martínez, A; Torregrosa-Quesada, M E; López-Muñoz, B; Cámara, R; Fajardo, C; Lamas, C; Picó, A.
Affiliation
  • Martínez-López S; Research Laboratory, Alicante General University Hospital-ISABIAL, Alicante, Spain.
  • García-Martínez A; Research Laboratory, Alicante General University Hospital-ISABIAL, Alicante, Spain.
  • Torregrosa-Quesada ME; Biochemical Analysis Department, Alicante General University Hospital, Alicante, Spain.
  • López-Muñoz B; Endocrinology Department, Alicante General University Hospital, Alicante, Spain.
  • Cámara R; Endocrinology Department, La Fe Polytechnic and University Hospital, Valencia, Spain.
  • Fajardo C; Endocrinology Department, La Ribera University Hospital, Alzira, Valencia, Spain.
  • Lamas C; Endocrinology Department, Albacete University Hospital Complex, Albacete, Spain.
  • Picó A; Endocrinology Department, Alicante General University Hospital-ISABIAL, Miguel Hernández University, Calle Pintor Baeza, 12, 03010, Alicante, Spain. antonio.pico@umh.es.
J Endocrinol Invest ; 43(6): 859-863, 2020 Jun.
Article in En | MEDLINE | ID: mdl-31898311

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Adenoma / Receptors, Somatostatin / Receptors, Dopamine D2 / Neuroendocrine Tumors / Somatotrophs Type of study: Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Endocrinol Invest Year: 2020 Type: Article Affiliation country: Spain

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pituitary Neoplasms / Adenoma / Receptors, Somatostatin / Receptors, Dopamine D2 / Neuroendocrine Tumors / Somatotrophs Type of study: Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Endocrinol Invest Year: 2020 Type: Article Affiliation country: Spain